|
|
Bailey McCann, Opalesque New York: Ardian has closed its third growth fund on €530m. The fund beat its €500 million target and is twice the size of its predecessor fund which closed on €230 million in 2018.
Ardian's growth investing team looks for European companies that are fast growing and that are in key industries including digital, software and business services.
"Our approach has always been about more than just funding; we are focused on partnering with entrepreneurs to accelerate their business growth, achieve their ambitions and expand their footprint internationally. The current market presents one of the most exciting opportunities of the last 20 years for growth investment, particularly given the scale and pace of digitalization, and our team of experts bring best-in-class expertise and deep sector knowledge to support management teams with their growth. We have already made three investments from the fund, and our unique sourcing capabilities will see us invest further to help transform more growing companies with the next phase of their journeys." Alexis Saada, Head of Growth & Senior Managing Director, Ardian
The fund is already close to 25% deployed following three transactions in category leaders, including investments in Theradial, a dialysis solutions provider; My Pie, an innovative snacking concept; and Aprium Pharmacie, a pharmacy banner company.
The fund falls under the Article 8 of the European Union Sust...................... To view our full article Click here
|
|
RSS
